Connecticut Clinical Research Institute is a clinical research site located in Bristol, Connecticut, United States 06010.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Connecticut Clinical Research Institute has participated in 14 clinical trials with 5 currently active.
Therapeutic areas: Irritable Bowel Syndrome With Diarrhea (IBS-D), Eosinophilic Esophagitis, Ulcerative Colitis.
Sponsors: Ironwood Pharmaceuticals, Inc., Phathom Pharmaceuticals, Inc., Pfizer.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Connecticut Clinical Research Institute has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Connecticut Clinical Research Institute has 14 clinical trials on record, with 5 currently active. Their work covers Irritable Bowel Syndrome With Diarrhea (IBS-D), Eosinophilic Esophagitis, Ulcerative Colitis.
Yes — Connecticut Clinical Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.